Anirban Basu

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 39

Top Topics

Sickle Cell Disease

St Segment Elevation Myocardial Infarction

Decision Making

Top Venues

Health economics

Medical decision making : an international journal of the Society for Medical Decision Making

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Annals of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Noah E Hammarlund, Sarah K Holt, Anirban Basu, Ruth B Etzioni, Danté Morehead, Jenney R Lee, Erika M Wolff, John L Gore, Yaw A Nyame
Isolating the Drivers of Racial Inequities in Prostate Cancer Treatment. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (3) (2024)
Noah E Hammarlund, Sarah K Holt, Anirban Basu, Ruth B Etzioni, Danté Morehead, Jenney R Lee, Erika M Wolff, John L Gore, Yaw A Nyame
Isolating the Drivers of Racial Inequities in Prostate Cancer Treatment. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (3) (2024)
Noah E Hammarlund, Sarah K Holt, Anirban Basu, Ruth B Etzioni, Danté Morehead, Jenney R Lee, Erika M Wolff, John L Gore, Yaw A Nyame
Isolating the Drivers of Racial Inequities in Prostate Cancer Treatment. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Anirban Basu, Aaron N Winn, Kate M Johnson, Boshen Jiao, Emily Beth Devine, Jane Silva Hankins, Staci D Arnold, M A Bender, Scott D Ramsey
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Annals of internal medicine 177 (2) (2024)
Noah E Hammarlund, Sarah K Holt, Anirban Basu, Ruth B Etzioni, Danté Morehead, Jenney R Lee, Erika M Wolff, John L Gore, Yaw A Nyame
Isolating the Drivers of Racial Inequities in Prostate Cancer Treatment. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (3) (2024)
Noah E Hammarlund, Sarah K Holt, Anirban Basu, Ruth B Etzioni, Danté Morehead, Jenney R Lee, Erika M Wolff, John L Gore, Yaw A Nyame
Isolating the Drivers of Racial Inequities in Prostate Cancer Treatment. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (3) (2024)
Anirban Basu, Aaron N Winn, Kate M Johnson, Boshen Jiao, Emily Beth Devine, Jane Silva Hankins, Staci D Arnold, M A Bender, Scott D Ramsey
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Annals of internal medicine (2024)
Anirban Basu, Aaron N Winn, Kate M Johnson, Boshen Jiao, Emily Beth Devine, Jane Silva Hankins, Staci D Arnold, M A Bender, Scott D Ramsey
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Annals of internal medicine 177 (2) (2024)
Anirban Basu, Aaron N Winn, Kate M Johnson, Boshen Jiao, Emily Beth Devine, Jane Silva Hankins, Staci D Arnold, M A Bender, Scott D Ramsey
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Annals of internal medicine 177 (2) (2024)
Anirban Basu, Aaron N Winn, Kate M Johnson, Boshen Jiao, Emily Beth Devine, Jane Silva Hankins, Staci D Arnold, M A Bender, Scott D Ramsey
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Annals of internal medicine 177 (2) (2024)
Noah E Hammarlund, Sarah K Holt, Anirban Basu, Ruth B Etzioni, Danté Morehead, Jenney R Lee, Erika M Wolff, John L Gore, Yaw A Nyame
Isolating the Drivers of Racial Inequities in Prostate Cancer Treatment. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (3) (2024)
Anirban Basu, Felipe Montano-Campos, Elbert S Huang, Neda Laiteerapong, Douglas Barthold
Updating and calibrating the Real-World Progression In Diabetes (RAPIDS) model in a non-Veterans Affairs population. Diabetes, obesity & metabolism (2024)
Silvia Moler-Zapata, Richard D Grieve, Anirban Basu, Stephen O'Neill
How does a local instrumental variable method perform across settings with instruments of differing strengths? A simulation study and an evaluation of emergency surgery. Health economics (2023)
Boshen Jiao, Anirban Basu
Associating Health-Related Quality-of-Life Score with Time Uses to Inform Productivity Measures in Cost-Effectiveness Analysis. PharmacoEconomics (2023)
Sara Khor, Patrick J Heagerty, Anirban Basu, Eric C Haupt, Lindsay Joe L Lyons, Erin E Hahn, Aasthaa Bansal
Racial Disparities in the Ascertainment of Cancer Recurrence in Electronic Health Records. JCO clinical cancer informatics 7 (2023)
Boshen Jiao, Kate M Johnson, Scott D Ramsey, M A Bender, Emily Beth Devine, Anirban Basu
Long-Term Survival with Sickle Cell Disease: A Nationwide Cohort Study of Medicare and Medicaid Beneficiaries. Blood advances (2023)
Anirban Basu
Use of race in clinical algorithms. Science advances 9 (21) (2023)
Wei-Jhih Wang, Aasthaa Bansal, Caroline Savage Bennette, Anirban Basu
Mimicking Clinical Trials Using Real-World Data: A Novel Method and Applications. Medical decision making : an international journal of the Society for Medical Decision Making 43 (3) (2022)
Stephen R Benoit, Dawei Guan, Vivian Fonseca, Lizheng Shi, Anirban Basu, Rodica Pop-Busui, Mohammed K Ali, Joshua Brown
Economic Evaluation of the $35 Insulin Copay Cap Policy in Medicare and Its Implication for Future Interventions. Diabetes care 45 (11) (2022)
Wei-Jhih Wang, Aasthaa Bansal, Caroline Savage Bennette, Anirban Basu
Mimicking Clinical Trials Using Real-World Data: A Novel Method and Applications. Medical decision making : an international journal of the Society for Medical Decision Making 43 (3) (2022)
Wei-Jhih Wang, Aasthaa Bansal, Caroline Savage Bennette, Anirban Basu
Mimicking Clinical Trials Using Real-World Data: A Novel Method and Applications. Medical decision making : an international journal of the Society for Medical Decision Making (2022)
Boshen Jiao, Jane S Hankins, Beth Devine, Martha Barton, M Bender, Anirban Basu
Application of validated mapping algorithms between generic PedsQL scores and utility values to individuals with sickle cell disease. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 31 (9) (2022)
Kate M Johnson, Boshen Jiao, M A Bender, Scott D Ramsey, Beth Devine, Anirban Basu
Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease. PloS one 17 (4) (2022)
Kangho Suh, Anirban Basu, Josh J Carlson, Kelley R Branch
Exploring Medication Adherence with P2Y12 Inhibitors Using Conditional and Unconditional Quantile Regression Approaches. American journal of cardiovascular drugs : drugs, devices, and other interventions 21 (2) (2021)
Alice M Ellyson, Anirban Basu
Do pharmaceutical prices rise anticipating branded competition? Health economics 30 (5) (2021)
Aasthaa Bansal, Patrick J Heagerty, Lurdes Y T Inoue, David L Veenstra, Charles J Wolock, Anirban Basu
A Value-of-Information Framework for Personalizing the Timing of Surveillance Testing. Medical decision making : an international journal of the Society for Medical Decision Making (2021)
Douglas Barthold, Elizabeth Brouwer, Lee J Barton, David E Arterburn, Anirban Basu, Anita P Courcoulas, Cecelia L Crawford, Peter N Fedorka, Heidi Fischer, Benjamin B Kim, Edward C Mun, Sameer B Murali, Kristi L Reynolds, Tae K Yoon, Robert E Zane, Karen J Coleman
Minimum Threshold of Bariatric Surgical Weight Loss for Initial Diabetes Remission. Diabetes care (2021)
Meng Li, Anirban Basu, Caroline S Bennette, David L Veenstra, Louis P Garrison
Do cancer treatments have option value? Real-world evidence from metastatic melanoma. Health economics 28 (7) (2020)
Sarah Beth L Barnett, Norma B Coe, Jeffrey R Harris, Anirban Basu
Washington's privatization of liquor: effects on household alcohol purchases from Initiative 1183. Addiction (Abingdon, England) 115 (4) (2020)
Nathaniel Hendrix, Deirdre Weymann, Jagori Chatterjee, Devender S Dhanda, Anirban Basu, David L Veenstra, Josh J Carlson
Provider preferences for resolving uncertainty and avoiding harms in precision medicine: a discrete choice experiment. Personalized medicine 17 (5) (2020)
Karen J Coleman, Heidi Fischer, David E Arterburn, Douglas Barthold, Lee J Barton, Anirban Basu, Anita P Courcoulas, Cecelia L Crawford, Peter N Fedorka, Benjamin B Kim, Edward Mun, Sameer B Murali, Kristi L Reynolds, Kangho Suh, Rong Wei, Tae K Yoon, Robert Zane
Effectiveness of Gastric Bypass Versus Gastric Sleeve for Cardiovascular Disease: Protocol and Baseline Results for a Comparative Effectiveness Study. JMIR research protocols 9 (4) (2020)
Anirban Basu, Kritee Gujral
Evidence generation, decision making, and consequent growth in health disparities. Proceedings of the National Academy of Sciences of the United States of America 117 (25) (2020)
Anirban Basu, Min-Woong Sohn, Brian Bartle, Kwun Chuen Gary Chan, Jennifer M Cooper, Elbert Huang
Development and Validation of the Real-World Progression in Diabetes (RAPIDS) Model. Medical decision making : an international journal of the Society for Medical Decision Making 39 (2) (2019)
Peter J Neumann, David Daeho Kim, Thomas A Trikalinos, Mark J Sculpher, Joshua A Salomon, Lisa A Prosser, Douglas K Owens, David O Meltzer, Karen M Kuntz, Murray Krahn, David Feeny, Anirban Basu, Louise B Russell, Joanna E Siegel, Theodore G Ganiats, Gillian D Sanders
Future Directions for Cost-effectiveness Analyses in Health and Medicine. Medical decision making : an international journal of the Society for Medical Decision Making 38 (7) (2019)
Kai Yeung, Anirban Basu, Ryan N Hansen, Sean D Sullivan
Price elasticities of pharmaceuticals in a value based-formulary setting. Health economics 27 (11) (2018)
Anirban Basu, Norma B Coe, Cole G Chapman
2SLS versus 2SRI: Appropriate methods for rare outcomes and/or rare exposures. Health economics 27 (6) (2018)
Anirban Basu
Comment: Manski's views on patient care under uncertainty. Health economics 27 (10) (2018)
Anirban Basu, David Meltzer
Decision Criterion and Value of Information Analysis: Optimal Aspirin Dosage for Secondary Prevention of Cardiovascular Events. Medical decision making : an international journal of the Society for Medical Decision Making 38 (4) (2018)
Sungchul Park, Anirban Basu
Alternative evaluation metrics for risk adjustment methods. Health economics 27 (6) (2018)